ATC
BNTX icon

Adirondack Trust Company’s BioNTech BNTX Stock Holding History

Adirondack Trust Company’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$5K – 405
2021
Q1 		$5K Hold
50
– – ﹤0.01% 331
2020
Q4 		$6K Hold
50
– – ﹤0.01% 300
2020
Q3 		$3K Hold
50
– – ﹤0.01% 305
2020
Q2 		$4K Buy
+50
New +$2.5K ﹤0.01% 292

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adirondack Trust Company's BNTX Position: Q2 2021 in Review

Adirondack Trust Company sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 50 shares — an estimated $5K sold.

Adirondack Trust Company first reported a position in BNTX in Q2 2020 and held it in 4 quarters. The position peaked at $6K in Q4 2020. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Adirondack Trust Company reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • Adirondack Trust Company sold 50 BioNTech shares in Q2 2021, an estimated $5K.
  • Adirondack Trust Company first reported a position in BioNTech in Q2 2020 and held it in 4 quarters.
  • Adirondack Trust Company's BioNTech position peaked at $6K in Q4 2020.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Adirondack Trust Company's 13F filing for Q2 2021, filed 15 Jul 2021.